Clinical Trial Update: Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin-assisted therapy for major depressive disorder in patients with non-small cell lung cancer. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Non-small Cell Lung Cancer

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Alan Davis | Conditions: Lung Non-Small Cell Carcinoma, Unipolar Depression | Phase 2 | Status: RECRUITING